# Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the Body

> **NCT04281147** · — · COMPLETED · sponsor: **Bayer** · enrollment: 4301 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Radium-223 dichloride (Xofigo, BAY88-8223)

## Key facts

- **NCT ID:** NCT04281147
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-24
- **Primary completion:** 2021-06-22
- **Final completion:** 2021-06-22
- **Target enrollment:** 4301 (ACTUAL)
- **Last updated:** 2022-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04281147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04281147, "Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the Body". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04281147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*